Dr. William St. Clair, Duke University Doctor on New Drug Benefits Patients with Sjögren’s Disease 6/6/2024
WPTF Morning News · WPTF FM 92.9 AM 680
June 6, 20245m 31s
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In a phase 2 clinical trial, a new drug under development significantly reduced both the symptoms and disease process of a condition called Sjӧgren’s disease. The international study was led by E. William St. Clair, M.D., the W. Lester Brooks Jr. Professor of Medicine in the Division of Rheumatology and Immunology at Duke University School of Medicine. The results will appear June 5 in the journal Nature Medicine. Dr. St. Clair joins Chris Edwards.